Dr. Nicholson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1415 Old Weisgarber Rd
Sutie 200
Knoxville, TN 37909Phone+1 865-934-5800Fax+1 865-934-5801
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1992 - 1995
Wright State University Boonshoft School of MedicineClass of 1992
Certifications & Licensure
TN State Medical License 1995 - 2019
KY State Medical License 2003 - 2015
NC State Medical License 2000 - 2015
Clinical Trials
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 79 citationsDocetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-In...Karen L. Tedesco, Ann D. Thor, David H. Johnson, Yu Shyr, K. A. Blum
Journal of Clinical Oncology. 2004-03-15 - 10 citationsOngoing and planned trials of hormonal therapy and trastuzumab.Brenda P. Nicholson
Seminars in Oncology. 2000-12-01 - 5 citationsPaclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer.Brenda P. Nicholson, David M. Paul, Kenneth R. Hande, Yu Shyr, Michael Meshad
Clinical Breast Cancer. 2000-07-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
